BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20399520)

  • 1. Cardiac side-effects of cancer chemotherapy.
    Monsuez JJ; Charniot JC; Vignat N; Artigou JY
    Int J Cardiol; 2010 Sep; 144(1):3-15. PubMed ID: 20399520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity induced by tyrosine kinase inhibitors.
    Orphanos GS; Ioannidis GN; Ardavanis AG
    Acta Oncol; 2009; 48(7):964-70. PubMed ID: 19734999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and prevention of cardiac complications of cancer chemotherapy.
    Monsuez JJ
    Arch Cardiovasc Dis; 2012 Nov; 105(11):593-604. PubMed ID: 23177488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of systemic cancer treatment.
    Senkus E; Jassem J
    Cancer Treat Rev; 2011 Jun; 37(4):300-11. PubMed ID: 21126826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into cardiovascular side-effects of modern anticancer therapeutics.
    Stortecky S; Suter TM
    Curr Opin Oncol; 2010 Jul; 22(4):312-7. PubMed ID: 20535072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
    Jensen BV
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.
    Medina PJ; Goodin S
    Clin Ther; 2008 Aug; 30(8):1426-47. PubMed ID: 18803986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer.
    Du XL; Xia R; Liu CC; Cormier JN; Xing Y; Hardy D; Chan W; Burau K
    Cancer; 2009 Nov; 115(22):5296-308. PubMed ID: 19672997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular toxicity of some cancer agents (others than anthracyclines, fluoropyrimidines and trastuzumab)].
    Saintigny P; Chouahnia K; Charniot JC; Breau JL
    Bull Cancer; 2004 Nov; 91 Suppl 3():174-84. PubMed ID: 15899625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac toxicity from systemic cancer therapy: a comprehensive review.
    Curigliano G; Mayer EL; Burstein HJ; Winer EP; Goldhirsch A
    Prog Cardiovasc Dis; 2010; 53(2):94-104. PubMed ID: 20728696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiotoxicity of chemotherapies].
    Castel M; Despas F; Modesto A; Gales C; Honton B; Galinier M; Senard JM; Pathak A
    Presse Med; 2013 Jan; 42(1):26-39. PubMed ID: 22727981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The side effects and safety of the echo-dobutamine test. The experience with 373 patients].
    Fetiveau R; Lanzarini L; Poli A; Diotallevi P; Mussini MF; Montemartini C; Previtali M
    G Ital Cardiol; 1995 Feb; 25(2):193-201. PubMed ID: 7642024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
    Katerinis I; Nguyen QV; Magnin JL; Descombes E
    Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
    Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
    Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer drugs and the heart: importance and management.
    Suter TM; Ewer MS
    Eur Heart J; 2013 Apr; 34(15):1102-11. PubMed ID: 22789916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular complications in oncology patients].
    Suzuki Y; Tokuda Y
    Nihon Rinsho; 2003 Jun; 61(6):984-9. PubMed ID: 12806947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide.
    Morandi P; Ruffini PA; Benvenuto GM; La Vecchia L; Mezzena G; Raimondi R
    Bone Marrow Transplant; 2001 Aug; 28(3):277-82. PubMed ID: 11535996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.